Eledon Pharmaceuticals, Inc. (ELDN) — 10-K/A Filings
All 10-K/A filings from Eledon Pharmaceuticals, Inc.. Browse 3 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (3)
-
Eledon Restates 2023-2024 Financials, Cites No Cash Impact
— Aug 14, 2025 Risk: medium
Eledon Pharmaceuticals, Inc. (ELDN) filed a 10-K/A on August 14, 2025, to restate its financial statements for the fiscal years ended December 31, 2024, and 202 -
Eledon Pharma Files 2023 Annual Report Amendment
— Aug 19, 2024 Risk: medium
Eledon Pharmaceuticals, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023. The filing includes information on v -
Eledon Pharmaceuticals Files 10-K/A Amendment
— Apr 26, 2024 Risk: low
Eledon Pharmaceuticals, Inc. (ELDN) filed a Amended Annual Report (10-K/A) with the SEC on April 26, 2024. Eledon Pharmaceuticals, Inc. filed an amended 10-K re
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX